COVID‐19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience

Substantial changes in the management of cancer patients have been required worldwide in response to the COVID‐19 pandemic. Beyond the due details on the primitive cancer site and setting at diagnosis, these latter adaptions are most commonly exemplified by a significant reduction in the screening o...

Descripción completa

Detalles Bibliográficos
Autores principales: Barba, Maddalena, Krasniqi, Eriseld, Pizzuti, Laura, Mazzotta, Marco, Marinelli, Daniele, Giuliano, Greta, Di Liso, Francesca Sofia, Cappuzzo, Federico, Landi, Lorenza, Tomao, Silverio, Ciliberto, Gennaro, Vici, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251317/
https://www.ncbi.nlm.nih.gov/pubmed/33677841
http://dx.doi.org/10.1111/tbj.14204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251317/
https://www.ncbi.nlm.nih.gov/pubmed/33677841
http://dx.doi.org/10.1111/tbj.14204

Ejemplares similares